| 44499-2 |
Herpes simplex virus 2 Ag |
PrThr |
Urethra |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus 2 Ag [Presence] in Urethra |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44499-2 |
|
|
|
|
Both |
|
|
|
0 |
HSV2 Ag Urth Ql |
|
|
|
N |
|
Antigen; Antigens; Genital tract; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Urth |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 445-7 |
Roxithromycin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Roxithromycin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
445-7 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Roxithromycin Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; Assoral; AST; c161; Cirumycin; Claramid; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Macrosil; Overal; Point in time; Random; Rossitrol; Rotesan; Rotramin; Rulid; Surlid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4450-3 |
traZODone |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
traZODone [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4450-3 |
|
|
|
|
Observation |
|
|
|
0 |
traZODone Dose |
|
|
|
Y |
|
Desyrel; Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random; Trazon; Trialodine |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44500-7 |
Herpes simplex virus 2 Ag |
PrThr |
Cvx |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus 2 Ag [Presence] in Cervix |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44500-7 |
|
|
|
|
Both |
|
|
|
0 |
HSV2 Ag Cvx Ql |
|
|
|
N |
|
Antigen; Antigens; Cervix; Genital tract; Gyn; Gynecology; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44501-5 |
Herpes simplex virus 2 Ag |
PrThr |
Thrt |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus 2 Ag [Presence] in Throat |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44501-5 |
|
|
|
|
Both |
|
|
|
0 |
HSV2 Ag Throat Ql |
|
|
|
N |
|
Antigen; Antigens; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Throat; Upper respiratory |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44502-3 |
Herpes simplex virus 2 Ag |
PrThr |
Tiss |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus 2 Ag [Presence] in Tissue |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44502-3 |
|
|
|
|
Both |
|
|
|
0 |
HSV2 Ag Tiss Ql |
|
|
|
N |
|
Antigen; Antigens; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44503-1 |
Herpes simplex virus 2 DNA |
PrThr |
Amnio fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44503-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV2 DNA Amn Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44504-9 |
Herpes simplex virus Ab |
PrThr |
Body fld |
Pt |
Ord |
IF |
|
ACTIVE |
Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44504-9 |
|
IF |
|
|
Both |
|
|
|
0 |
HSV Ab Fld Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; Herp splx; HSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44505-6 |
Herpes simplex virus Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44505-6 |
|
|
|
|
Both |
|
|
|
0 |
HSV IgG CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Herp splx; HSV; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44506-4 |
Herpes simplex virus Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44506-4 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44507-2 |
Herpes simplex virus Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44507-2 |
|
IF |
|
|
Both |
|
|
|
0 |
HSV IgM Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Herp splx; HSV; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44508-0 |
Herpes simplex virus Ag |
PrThr |
Cvx |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Cervix |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44508-0 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ag Cvx Ql |
|
|
|
N |
|
Antigen; Antigens; Cervix; Genital tract; Gyn; Gynecology; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44509-8 |
Herpes simplex virus Ag |
PrThr |
Penis |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Penis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44509-8 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ag Penis Ql |
|
|
|
N |
|
Antigen; Antigens; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pen; Penile; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4451-1 |
Triamterene |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Triamterene [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4451-1 |
|
|
|
|
Observation |
|
|
|
0 |
Triamterene Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; Dyrenium; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44510-6 |
Herpes simplex virus Ag |
PrThr |
Vag |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Vaginal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44510-6 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ag Vag Ql |
|
|
|
N |
|
Antigen; Antigens; Genital vaginal; Gyn; Gynecology; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44511-4 |
Herpes simplex virus Ag |
PrThr |
Eye |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Eye |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44511-4 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ag Eye Ql |
|
|
|
N |
|
Antigen; Antigens; Eyeball; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Occular; Oculis; Ophthalmologic; Optic globe; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vision; Visual |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44512-2 |
Herpes simplex virus Ag |
PrThr |
Nose |
Pt |
Ord |
|
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Nose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44512-2 |
|
|
|
|
Both |
|
|
|
0 |
HSV Ag Nose Ql |
|
|
|
N |
|
Antigen; Antigens; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44513-0 |
Herpes simplex virus Ag |
PrThr |
Bronchial |
Pt |
Ord |
IF |
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44513-0 |
|
IF |
|
|
Both |
|
|
|
0 |
HSV Ag Bronch Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Bro; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; HSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44514-8 |
Herpes simplex virus Ag |
PrThr |
CSF |
Pt |
Ord |
IA |
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44514-8 |
|
IA |
|
|
Both |
|
|
|
0 |
HSV Ag CSF Ql IA |
|
|
|
N |
|
Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; HSV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44515-5 |
Herpes simplex virus Ag |
PrThr |
Cvx |
Pt |
Ord |
IA |
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Cervix by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44515-5 |
|
IA |
|
|
Both |
|
|
|
0 |
HSV Ag Cvx Ql IA |
|
|
|
N |
|
Antigen; Antigens; Cervix; EIA; ELFA; ELISA; Enzyme immunoassay; Genital tract; Gyn; Gynecology; Herp splx; HSV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44516-3 |
Herpes simplex virus Ag |
PrThr |
Cvx |
Pt |
Ord |
IF |
|
ACTIVE |
Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44516-3 |
|
IF |
|
|
Both |
|
|
|
0 |
HSV Ag Cvx Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cervix; DFA; FA; Fluorescent antibody; Fluoresent; Genital tract; Gyn; Gynecology; Herp splx; HSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF |
2.58 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44517-1 |
Herpes simplex virus DNA |
PrThr |
Amnio fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44517-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV DNA Amn Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44518-9 |
Herpes simplex virus DNA |
PrThr |
Ser/Plas |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44518-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV DNA SerPl Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44519-7 |
Herpes virus 6 Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Herpes virus 6 Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44519-7 |
|
|
|
|
Both |
|
|
|
0 |
HHV6 Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4452-9 |
Triazolam |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Triazolam [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4452-9 |
|
|
|
|
Observation |
|
|
|
0 |
Triazolam Dose |
|
|
|
Y |
|
APO-TRIAZO; Dose med or substance; DRUG DOSES; Halcion; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
